BUSINESS ACCOUNT
Access reports individually or via Subscription
Receive monthly invoices with payment via CSA or hard dollars
Analyst access
Free Trial Subscriptions
Team account with shared subscriptions
Advanced analytics to track research consumption and performance
4Q'25 vs. 4Q'24 Results Sales: € 1.622 Bn (+5.2% vs. +3.6% BS(e) and +4.3% consensus); EBITDA: € 577.9 M (+9.3% vs. +4.5% BS(e) and +5.9% consensus); FY2025 vs. FY2024 Results Sales: € 6.517 Bn (+6.1% vs. +5.7% BS(e) and +5.9% consensus); EBITDA: € 2.507 Bn (+7.4% vs. +6.3% BS(e) and +6.6% consensus);
4Q'25 vs. 4Q'24 Results Sales: € 1.982 Bn (+0.4% vs. +1.1% BS(e) and -1.7% consensus); EBITDA: € 467.0 M (-11.2% vs. -10.4% BS(e) and -10.8% consensus); EBIT: € 271.41 M (-27.0% vs. -8.6% BS(e) and -9.4% consensus); Net Profit: € 98.25 M (+42.4% vs. +65.9% BS(e) and +133.1% consensus); FY2025 vs. FY2024 Results Sales: € 7.524 Bn (+4.3% vs. +4.5% BS(e) and +3.8% consensus); EBITDA: € 1.825 Bn (+2.6% vs. +2.8% BS(e) and +2.7% consensus); EBIT: € 1.243 Bn (+4.3% vs. +10.1% BS(e) and +9.8% consensus...
4Q'25 vs. 4Q'24 Results Sales: € 884.1 M (-11.8% vs. -4.5% BS(e)); EBITDA: € 80.8 M (+46.4% vs. +9.4% BS(e)); EBIT: € 75.8 M (+86.7% vs. -8.1% BS(e)); Net Profit: € 47.3 M (+463.1% vs. -77.8% BS(e)); FY2025 vs. FY2024 Results Sales: € 3.455 Bn (-5.4% vs. -3.4% BS(e)); EBITDA: € 194.0 M (+36.5% vs. +22.2% BS(e)); EBIT: € 128.0 M (+73.0% vs. +21.0% BS(e)); Net Profit: € 1.7 M (€ -49.9 M in FY2024 vs. € -43.74 M BS(e));